N/A N=159 Decreasing Delirium Through Music in Critically Ill Older Adults
Intensive Care Unit Delirium · Pain · Anxiety
Primary: Days Free of Delirium and Coma — 2.5; 3 Delirium/coma-free days by day 7 — p=0.775
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=16 Phase 1b Study of DCR-AUD in Healthy Volunteers
Alcohol Use Disorder
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) — 11; 3; 0; 0 Participants
N/A N=558 A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).
ATTR-CM
Primary: Number of Participants According to Clinical Diagnosis Predicted Using the Machine Learning (ML) Algorithm — 203; 133; 35; 187 Participants
Phase 1 N=19 A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers
Drug Interaction
Primary: To Evaluate the Impact of C21 on the Pharmacokinetics (PK) of Caffeine and Paraxanthine (Cmax) — 2290; 2871; 2784; 546.4 ng/mL
N/A N=17 Chronic Passive Heating in Individuals With T2DM
Type2 Diabetes
Primary: Insulin Sensitivity — 0.31; 0.33; 0.10; 0.10 AU
Phase 1 N=23 A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults
Healthy Participants
Primary: Number of Participants Reporting Treatment-Emergent Adverse Events (TEAEs) — 1; 2; 3; 2 Participants
N/A N=70 Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women
Obesity · Weight Gain, Maternal
Primary: Percent Change in Body Weight — 10.9; 9.6 percentage change
N/A N=83 HoloLens: an Objective Alternative to the Operator's Memory
Virtual Reality · Anesthesia · Epidural
Primary: Procedure Time — 7.3; 4.5 Minutes — p=0.02
N/A N=445 Testing Legally Feasible Options Studies 2/3
Tobacco Use
Primary: Self-reported Cigarette Smoking Risk After Shopping in the StoreLab — .59; .52; .39 proportion of participants
N/A N=704 Oregon Military Employee Sleep and Health Study
Well-Being · Sleep · Health Behavior
Primary: Self-Reported Sleep Duration — 7.43; 7.34 Hours
N/A N=38 Mobile Health (mHealth) Nutrition Intervention for Children With Autism Spectrum Disorder
Diet Modification
Primary: 3-month Fruit and Vegetable Intake — 2.16; 3.01 Servings per day
Phase 1 N=35 Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam
Safety Issues · Pharmacokinetics · Drug Interaction
Primary: Period I, Part I - Linaprazan Glurate and Linaprazan PK Parameters With and Without Co-administration of Clarithromycin - AUC0-inf — 13950; 42840; 137.3; 165.9 h*nmol/L
N/A N=481 To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma
Renal Cell Carcinoma
Primary: Number of Participants With Different Type of Adverse Events — 232; 184; 141; 106 Participants
Phase 3 N=33 Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants
Immunization
Primary: Antibody Prevalence Rate Against Anti-PRP With 1 μg/mL or Higher, Diphtheria Toxin, Pertussis, Tetanus Toxin, and Polio Virus, Defined as the Percentage of Participants…
N/A N=103 Delaware Physical Exercise and Activity for Knee Osteoarthritis
Knee Osteoarthritis
Primary: Change in Moderate-to-vigorous Intensity Physical Activity — 0.7; 2.6; 2.7; 1.6 min/day of MVPA